Fluke Biomedical, a manufacturer of biomedical test instruments, has announced the acquisition of Unfors RaySafe.
With this acquisition Fluke Biomedical adds industry leading quality assurance devices for diagnostic x-ray from Unfors RaySafe to its product offering.
With an enhanced portfolio especially in the fields of diagnostic x-ray, real time dose monitoring systems for medical personnel, and patient dose tracking software solutions, the Unfors RaySafe product line will broaden Fluke Biomedical’s customer base and answer market demands with innovative and state-of-the-art solutions.
Fluke Biomedical’s goal with this acquisition is to provide healthcare providers, institutions and medical device manufacturers with a complete portfolio of test equipment. Both companies see the user-friendliness of their products, combined with advanced technology and maximum measurement accuracy as their major assets.
Fluke Biomedical general manager Eric Conley noted the acquisition of Unfors RaySafe brings to the company a strong team that has delivered leading innovation to the radiation test and safety markets.
"The combination of Unfors RaySafe and Fluke Biomedical accelerates our ability to provide a broad portfolio of world class test equipment to our customers," Conley added.
Fresh perspectives and product enhancements, coupled with the commitment to customer satisfaction will remain the hallmark of both organizations.